Related Experiment Video
Updated: Apr 23, 2026
08:24
Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
19.2K
The intestinal microbiota in inflammatory bowel diseases
1Division of Gastroenterology and Hepatology, Center for Gastrointestinal Biology and Disease, Department of Medicine, Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA.
Nestle Nutrition Institute Workshop Series
|September 18, 2014
Summary
The gut microbiota plays a key role in inflammatory bowel diseases like Crohn's disease and ulcerative colitis (UC). Dysbiosis, an imbalance in gut bacteria, is linked to disease severity and immune responses.
Area of Science:
- Gastroenterology
- Microbiology
- Immunology
Background:
- Resident microbiota are implicated in Crohn's disease, pouchitis, and ulcerative colitis (UC), disorders concentrated in high-bacterial areas.
- Antibiotics and probiotics show efficacy in treating pouchitis, Crohn's colitis, and UC, highlighting the role of gut bacteria.
- Serologic markers for intestinal bacteria/yeast in Crohn's disease patients may predict disease aggressiveness.
Purpose of the Study:
- To explore the role of resident microbiota in inflammatory bowel diseases.
- To investigate the link between gut bacteria profiles (dysbiosis) and disease pathogenesis.
- To understand how specific bacterial species influence immune responses and inflammation.
Main Methods:
- Analysis of clinical and experimental evidence on microbiota in inflammatory bowel diseases.
- Examination of serologic markers in Crohn's disease patients.
- Assessment of fecal and mucosally associated enteric bacteria profiles (dysbiosis).
- Review of animal models of immune-mediated enterocolitis.
Main Results:
- Abnormal bacterial profiles (dysbiosis) are observed in Crohn's disease, UC, pouchitis, and experimental enterocolitis.
- Aggressive bacterial species proliferate, while protective subsets decrease, correlating with disease.
- Protective bacteria produce short-chain fatty acids (e.g., butyrate) that enhance barrier function and regulate immune responses.
- Certain Clostridia species stimulate regulatory T cells, inhibiting intestinal inflammation.
- Animal models confirm resident bacteria stimulate effector immune cells in susceptible hosts.
Conclusions:
- Gut microbiota dysbiosis is a significant factor in inflammatory bowel diseases.
- Specific bacterial compositions influence disease activity and immune modulation.
- Therapeutic strategies targeting the microbiota hold promise for treating IBD.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
21
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
21
01:26Inflammatory Bowel Disease I: Introduction
27
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
27
01:27Microbiota of the Large Intestine
89
The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
89
01:27Microbiota of the Stomach and Small Intestine
72
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
72
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.5K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
22
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
22